Bioestadística
BIOESTADISTICA
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (12)
2022
-
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
2019
-
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
Oncologist, Vol. 24, Núm. 8, pp. e784-e792
-
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma
Theranostics, Vol. 9, Núm. 17, pp. 4946-4958
2017
-
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics
Journal of Molecular Diagnostics, Vol. 19, Núm. 4, pp. 575-588
-
Targeted sequencing reveals low-frequency variants in EPHA genes as markers of paclitaxel-induced peripheral neuropathy
Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1227-1235
2015
-
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients
Journal of Medical Genetics, Vol. 52, Núm. 10, pp. 647-656
-
Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations
International Journal of Cancer, Vol. 137, Núm. 8, pp. 1870-1878
2013
-
Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions
American Journal of Pathology, Vol. 182, Núm. 2, pp. 350-362
-
Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma
Endocrine-Related Cancer, Vol. 20, Núm. 4, pp. 611-619
-
Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways
Endocrine-Related Cancer, Vol. 20, Núm. 4, pp. 477-493
-
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis
Human Molecular Genetics, Vol. 22, Núm. 11, pp. 2169-2176
2011
-
The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Endocrine-Related Cancer, Vol. 18, Núm. 1, pp. 85-95